NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) dropped -6.61 percent to $26.01 Friday on volume of 3.37million shares. The intra-day range of the stock was … Continue reading NASDAQ most Volatile: InterMune Inc (NASDAQ:ITMN), ACADIA Pharmaceuticals (NASDAQ:ACAD), Clovis Oncology (NASDAQ:CLVS), Synageva BioPharma (NASDAQ:GEVA)

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Pingtan Marine Enterprise Ltd. (NASDAQ:PME) announced that the Company has declared a cash dividend of $0.01 per share of common stock outstanding, payable in cash on or about February 18, 2015 to shareholders of record on January 22, 2015. This marks the second consecutive quarterly dividend paid by the Company, which it intends to continue paying on a quarterly basis. Pingtan Marine Enterprise Ltd. (NASDAQ:PME) … Continue reading Stocks in Focus: Pingtan Marine Enterprise Ltd. (NASDAQ:PME), International Rectifier Corporation (NYSE:IRF), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Clovis Oncology (NASDAQ:CLVS), Endo International (NASDAQ:ENDP)